Ocugen Announces Amendment to Asset Purchase Agreement

    NEXT STORY
    ADMA Biologics Announces Data Presented at IDWeek 2019
    PREV STORY
    BriaCell Doses First Patient in Phase I/IIa Study Evaluating Bria-IMT™ in Combination with INCMGA00012 and Epacadostat in Patients with Advanced Breast Cancer
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Rexahn Announces $5 Million Registered Direct Offering

    ROCKVILLE, Md., Feb. 26, 2016 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN) today ...

    author_avatar
    NASDAQ Market News

    NBA All Star Alonzo Mourning and The Heat’s Wayne Ellington Launch Miami-Dade County Public School Gun Violence Prevention Initiative City-Wide with Sandy Hook Promise

    MIAMI, Sept. 19, 2016 (GLOBE NEWSWIRE) -- Former and current Miami Heat players Alonzo ...

    author_avatar
    NASDAQ Market News

    ITL Pharma Receives United States Patent Protection for Carcinin® Using Halogenated Phenol Ethers for Diagnostics, Antioxidant Protection and Drug Delivery

    KINGSPORT, Tenn., Nov. 26, 2018 (GLOBE NEWSWIRE) -- ITL Pharma, Inc. (ITL), a LIAS ...

    author_avatar
    NASDAQ Market News